Rheumatoid Arthritis

Hs-cTnT was found to be associated with a higher risk of MACE and all-cause mortality in a 10-year cohort study.

Although only 9 patients with FM and nasal septum deviation were included in the study, none met the criteria for fibromyalgia after surgery.

Patients with high RF concentration treated with CZP were more likely to achieve DAS28-CRP low disease activity at week 104 than those treated with adalimumab.

The MTX + HCQ group had a higher, but not statistically significant, incidence rate of TEAEs than the monotherapy group.

Panelists discuss advanced treatment options for rheumatoid arthritis, focusing on the SELECT-COMPARE trial's head-to-head data of upadacitinib versus adalimumab, the use of upadacitinib in active RA refractory to biologics (SELECT-BEYOND trial), and the remission rates of upadacitinib compared to abatacept (SELECT-CHOICE trial).

Investigators noted that a formal independent validation cohort needs to be developed in order to realize the full potential of the human model.

Experts discuss American College of Rheumatology guidelines on transitioning patients from TNF inhibitors to non-TNF targeted therapies like Janus kinase inhibitors, as well as factors influencing treatment switching decisions in clinical practice.

Experts discuss strategies for achieving low disease activity or remission in patients, including steps taken in clinical practice and methods for managing patient expectations regarding treatment outcomes.

Lengths of stay, total cost, and hospital mortality rates were similar between patients with and without rheumatoid arthritis.

Investigators also found that bDMARDs were used more often by patients with early-onset rheumatoid arthritis than by patients with late-onset.

A panel of medical experts explore how to evaluate and adjust rheumatoid arthritis treatment by adhering to ACR guidelines for conventional synthetic DMARDs and advanced therapies, focusing on optimizing patient care and treatment outcomes.

Medical experts explore how patient perceptions of rheumatoid arthritis can differ from disease activity assessments and provide an example of hidden symptoms revealed through further probing, along with the impact of therapy adjustments on achieving remission.

Other recent research found that having osteoarthritis increased the risk of developing carpal tunnel syndrome.

A recent study showed an association between pediatric acute-onset neuropsychiatric syndrome and inflammatory diathesis.

A panel of medical experts discuss complications and prognostic factors in uncontrolled rheumatoid arthritis.

A panel of medical experts discuss the prevalence and management of poorly controlled rheumatoid arthritis in clinical practice.

Adjusted analyses reveal a statistically significantly higher prescription medication cost in patients with RA compared to those without.

Results showed comparable clinically meaningful improvements in health-related quality of life among patients treated with the adalimumab reference product and biosimilar adalimumab-adbm.

A new study found approximately 40% with osteoarthritis and 36.3% with RA screened positive for anxiety, depression, and fibromyalgia.

Results showed particular heavy metals increased the risk of arthritis.

A panel of medical experts introduce themselves before diving into a discussion about remission achievement in rheumatoid arthritis.

A panel of medical experts discuss how clinical guidelines currently define clinical remission, as well as the clinical and economic benefits associated with clinical remission.

Inverse variance weighting showed beef intake, iron intake, process meat intake, cheese intake, and fresh and dried fruit intake were strongly linked to inflammatory arthritis.

Patients with inflammatory arthritis experiencing “long COVID” reported significantly worse disease activity.

Patients with lower levels of physical activity had higher levels of fatigue and a higher risk of sarcopenia.

Vitamin D insufficiency was linked to reduced muscle strength, increased pain, higher disease activity, fatigue, and worsened disease outcomes.

Higher PROs, which were indicative of worse disease activity, were more likely to be reported in the spring and fall months.

Erectile dysfunction was significantly linked to arthritis and remained significant even after adjustment.

Patients with RA had an increased risk of fractures compared with controls, with significant baseline predictors for future fractures identified as higher age, low body mass index, and low bone mineral density.